Myriad Genetics share price logo

Myriad Genetics

NASDAQ: MYGN

Small Cap

$5.57

-0.09

(-1.59%)

as on

Myriad Genetics Stock Performance

as on November 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $5.49
    $5.64
    downward going graph

    1.44%

    Downside

    1.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.74
    $8.09
    downward going graph

    50.81%

    Downside

    45.15%

    Upside

    downward going graph

Myriad Genetics share price movements today

Previous Close
$5.66
Open
$5.61
Volume
798.1K
Market Cap
$542.9M
Day's Low - High
$5.49 - $5.64
52 Week Low - High
$2.74 - $8.09

Myriad Genetics Historical Returns

1 Month Return
+ 39.95 %
3 Month Return
+ 82.62 %
1 Year Return
-16.37 %
3 Year Return
-68.83 %
5 Year Return
-80.5 %

Myriad Genetics Stock Fundamentals & Key Indicators

Check Myriad Genetics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$542.9M

EPS (TTM)

-1.3647

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.15

Industry PE ratio

-6.38

PEG Ratio

-0.09

EBITDA

-74.9M

Revenue (TTM)

803.6M

Profit Margin

68.33%

Return On Equity TTM

-40.40%

Myriad Genetics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Myriad Genetics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$542.9M-80.50%-4.1568.33%0.00%
StrongBuy$90.5B31.87%195.8549.44%0.00%
StrongBuy$55.5B11.57%47.4962.72%0.00%
StrongBuy$259.4B8.48%36.8741.44%0.26%
StrongBuy$163.9B-25.76%38.0858.59%0.65%

Stock Returns calculator for Myriad Genetics Stock including INR - Dollar returns

The Myriad Genetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Myriad Genetics investment value today

Current value as on today

₹88,622

Returns

-₹11,378

(-11.38%)

Returns from Myriad Genetics Stock

-₹16,366 (-16.37%)

Dollar Impact

₹4,988 (+4.99%)

Analyst Recommendation on Myriad Genetics Stock

Based on 3 analysts

BUY

33.33%

Buy

66.67%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Myriad Genetics. Average target price of $5.9

Myriad Genetics Share Price Target

Get share price movements and forecasts by analysts on Myriad Genetics.

What analysts predicted

5.59%UPSIDE

Target Price

$5.9

Current Price

$5.57

Analyzed by

3 Analysts

High

$8

Target

$5.90

Low

$5

Myriad Genetics target price $5.9, a slight upside of 5.59% compared to current price of $5.57. According to 3 analysts rating.

Indian Investors' Interest in Myriad Genetics Stock

Search interest for Myriad Genetics Stock has increased by 123% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:123% versus previous 30 day period

Myriad Genetics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
211
213
210
195
213
205
209
200
190
202
Gross Profit
147
149
150
134
151
143
146
137
127
137
Operating Income
-36
-20
-39
-29
-329
-23
-5
-30
-38
-39
EBITDA
-21
-4
-23
-14
-315
-9
8
-17
-26
-39
Interest Expense
0
0
0
0
1
3
4
4
4
4
Depreciation
15
15
14
14
14
12
12
12
12
-
Income Before Tax
-37
-21
-39
-29
-330
-26
-8
-34
-42
-43
Income Tax Expense
0
0
3
-29
0
1
-1
-
0
0
Net Income
-36
-22
-42
0
-330
-27
-7
-34
-43
-43
Net Profit Margin
69.55%
70.23%
71.65%
68.50%
71.23%
69.91%
69.97%
68.66%
66.60%
67.93%

Myriad Genetics Annual Profit & Loss

All numbers in Millions USD

Jun 2018
Jun 2019
Jun 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
851
638
557
690
678
753
837
824
Gross Profit
650
452
378
493
476
517
585
576
Operating Income
7
-231
-194
-190
-123
-144
-88
-67
EBITDA
85
-140
-123
12
-84
-197
-59
-330
Interest Expense
12
10
-
6
3
2
2
10
Depreciation
73
72
71
62
52
61
61
53
Income Before Tax
-
-223
-283
-57
-140
-262
-123
-395
Income Tax Expense
-4
-23
-59
-29
-28
1
3
-29
Net Income
4
-199
-223
-27
-112
-263
-127
-365
Net Profit Margin
76.38%
70.86%
68.01%
71.39%
70.22%
68.64%
69.89%
69.93%

Myriad Genetics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
-36
-22
-42
0
-330
-27
-7
-34
-43
-43
Operating Cash Flow
2
0
6
-16
-13
21
10
-15
-8
-6
Investing Cash Flow
-6
7
-5
-8
-6
-6
-6
-6
-3
-2
Financing Cash Flow
2
-3
2
13
2
56
-8
-3
2
0
Change in Cash
-4
7
2
-10
-17
71
-3
-25
-9
-9

Myriad Genetics Annual Cash Flow

All numbers in Millions USD

Jun 2018
Jun 2019
Jun 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
4
-199
-223
-27
-112
-263
-127
-365
Operating Cash Flow
83
60
-26
18
-106
-110
-8
1
Investing Cash Flow
-286
19
61
274
-77
31
-11
-27
Financing Cash Flow
182
-10
-1
-150
-8
152
-7
64
Change in Cash
-17
70
70
141
-192
74
-29
39

Global Institutional Holdings in Myriad Genetics

Check out the Institutions with significant holdings in Myriad Genetics.

Funds
Holdings
BlackRock, Inc.
16.60%
Larry Robbins
5.64%
Vanguard
5.32%
iShares
4.69%
VANGUARD INDEX FUNDS
4.16%

Myriad Genetics News & Key Events

    Insights on Myriad Genetics

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 190.69M → 202.70M (in $), with an average increase of 5.9% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 months, MYGN stock has moved up by 82.6%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Thermo Fisher Scientific, Inc. has given 21.9% return, outperforming this stock by 38.3%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Waters Corp has given 48.2% return, outperforming this stock by 117.0%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 4 quarters, -7.9M → -43.90M (in $), with an average decrease of 120.0% per quarter

    About Myriad Genetics

    Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
    OrganisationMyriad Genetics
    Headquarters322 North 2200 West, Salt Lake City, UT, 84116, US
    IndustryMedical - Diagnostics & Research
    CEOSamraat S. Raha

    Key Management of Myriad Genetics

    Name

    Title

    Mr. Matthew Scalo

    Senior Vice President of Investor Relations

    Dr. Patrick M. Burke Ph.D.

    Executive Vice President of Corporate & Business Development

    Ms. Shereen Solaiman

    Chief People Officer

    Mr. Samraat S. Raha

    President, CEO & Director

    Dr. Dale Muzzey Ph.D.

    Chief Scientific Officer

    Mr. Paul J. Diaz J.D.

    Consultant

    Mr. Raj Jampa

    Chief Technology Officer

    Ms. Jennifer L. Fox J.D.

    Chief Legal Officer

    Mr. Benjamin R. Wheeler

    CFO & Principal Accounting Officer

    Mr. Mark S. Verratti

    Chief Operating Officer

    FAQs

    What is Myriad Genetics share price today?

    Myriad Genetics share price today is $5.57 as on at the close of the market. Myriad Genetics share today touched a day high of $5.64 and a low of $5.49.

    What is the 52 week high and 52 week low for Myriad Genetics share?

    Myriad Genetics share touched a 52 week high of $8.09 on and a 52 week low of $2.74 on . Myriad Genetics stock price today i.e. is closed at $5.57,which is 31.11% down from its 52 week high and 103.28% up from its 52 week low.

    What is Myriad Genetics's market capitalisation today?

    Myriad Genetics market capitalisation is $0.00T as on .

    How to invest in Myriad Genetics Stock (MYGN) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Myriad Genetics on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Myriad Genetics Stock (MYGN) from India?

    Indian investors can start investing in Myriad Genetics (MYGN) shares with as little as ₹93.92250061035156 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹939.23 in Myriad Genetics stock (as per the Rupee-Dollar exchange rate as on ). Based on Myriad Genetics share’s latest price of $5.57 as on November 17, 2026 at 8:45 am IST, you will get 1.7953 shares of Myriad Genetics. Learn more about fractional shares .

    What are the returns that Myriad Genetics has given to Indian investors in the last 5 years?

    Myriad Genetics stock has given -80.5% share price returns and 26.58% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?